Multiple systems have been developed for grading the adverse effects (AEs) of cancer treatment.
The National Cancer Institute Common Toxicity Criteria (CTC) system has substantially …

Background A randomized phase 3 trial of the treatment of squamous-cell carcinoma of the
head and neck compared induction chemotherapy with docetaxel plus cisplatin and …

Purpose: To define outcome data and prognostic criteria for patients with metastatic renal
cell carcinoma (RCC) treated with interferon-alfa as initial systemic therapy. The data can be …

Background Cetuximab, a chimeric mouse–human IgG1 monoclonal antibody against the
epidermal growth factor receptor, is approved for use in colorectal cancer and squamous-cell …

Quality of life (QOL) has become an increasingly important outcome measure for patient's
undergoing treatment for a wide array of illnesses. QOL is a global construct that reflects a …

Background Early reports indicate that AKI is common among patients with coronavirus
disease 2019 (COVID-19) and associated with worse outcomes. However, AKI among …

Cancer-related fatigue is defined as a distressing, persistent, subjective sense of physical,
emotional, and/or cognitive tiredness or exhaustion related to cancer or cancer treatment that …

Answer questions and earn CME/CNE Oral complications resulting from cancer and cancer
therapies cause acute and late toxicities that may be underreported, underrecognized, and …

While studies in animal models have linked Toll-like receptor (TLR) 4 signaling to kidney
injury induced by ischemia and reperfusion, the relevance of TLR4 activation to allograft injury …

Purpose High epidermal growth factor receptor (EGFR) gene copy number is associated
with poor prognosis in lung cancer, but such findings have not been reported for HNSCC. A …